# Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy

> **NCT01422018** · NA · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Diabetes Complications

## Interventions

- **DRUG:** Avastin (bevacizumab)

## Key facts

- **NCT ID:** NCT01422018
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422018, "Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01422018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*